Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.43 |
| ▸ | PTGDR2 | Q9Y5Y4 | 11/20 | 0.41 |
| ▸ | PTGDR | Q13258 | 3/20 | 0.41 |
| ▸ | PPME1 | Q9Y570 | 2/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.35 |
| ▸ | PTGES | O14684 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | FLT1 | P17948 | 1/20 | 0.33 |
| ▸ | FLT4 | P35916 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3968730 | 0.95 | PTGDR2 (0.42) | RAPGEF4PTGDR2PTGDRPPME1HTR6 | |
| SCHEMBL3971663 | 0.93 | PTGDR2 (0.45) | RAPGEF4PTGDR2PTGDRPPME1HTR6 | |
| SCHEMBL3972665 | 0.92 | PTGDR2 (0.38) | RAPGEF4PTGDR2PTGDRPPME1HTR6 | |
| SCHEMBL3974788 | 0.92 | PTGDR2 (0.46) | RAPGEF4PTGDR2PTGDRPPME1 | |
| SCHEMBL3964356 | 0.91 | PTGDR2 (0.39) | RAPGEF4PTGDR2PTGDRPPME1HTR6 | |
| SCHEMBL3967149 | 0.90 | RAPGEF4 (0.42) | RAPGEF4PTGDR2PTGDRPPME1AKR1C3 | |
| SCHEMBL3966242 | 0.90 | PTGDR2 (0.38) | RAPGEF4PTGDR2PTGDRPPME1HTR6 | |
| SCHEMBL3969343 | 0.89 | PTGDR2 (0.39) | RAPGEF4PTGDR2PTGDRPPME1HTR6 | |
| SCHEMBL3971500 | 0.87 | PTGDR2 (0.39) | RAPGEF4PTGDR2PTGDRPTGESALOX5 | |
| SCHEMBL3968885 | 0.85 | PPME1 (0.37) | RAPGEF4PTGDR2PPME1AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009044147-A1 | INDOLIZINE DERIVATIVES WITH CRTH2 RECEPTOR AFFINITY FOR THE TREATMENT OF INFLAMMATORY DISEASES | ARGENTA DISCOVERY LIMITED (GB) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009044147-A1 | INDOLIZINE DERIVATIVES WITH CRTH2 RECEPTOR AFFINITY FOR THE TREATMENT OF INFLAMMATORY DISEASES | ARGENTA DISCOVERY LIMITED (GB) | 2009-04-09 | — | — | WO | disclosed |